제5회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 블록포스트 가이드포스트 fn아이포커스 파이낸셜뉴스재팬 fnMICE fn이노에듀 fn투어


지난행사목록

본문

◎ 06월12일
Section Time Schedule c.f.
Opening Ceremony 09:00~09:30 <Opening Remark>
Seong-Cheol Kweon
President, The Financial News

<Congratulatory Remark>
Je-Se Oh
A Chairman, Health and  Welfare Committee
Young Chin
Minister, Health and Welfare
Seung Chung
Minister, Food and Drug Safety
Keynote Address 09:30~10:00 Jae-Hyun Kim
President, Korea Advanced Institute of Science and
Technology / Chemistry
 Session 1. The Korean Cooperative Model for New Drug Development   
Speech 10:00~10:30 Stephen Sunghan Yoo
Branch Chief, MRTB/ RRP/ NCI/ NIH
Speech 10:30~11:00 Michele Liuzzi
CEO, Institut Pasteur Korea
Speech 11:00~11:30 Sung-Joo Lee
Head, AP Research, Therapeutic strategic Unit AP R&D, Sanofi
Luncheon 11:30~12:50 Luncheon
 Session 2. Challenge and Mission: Hope in the Development of the Innovative Global Drug   
Speech 12:50~13:20 Jee-Woong Son
Vice-President(Head of R&D), Hanmi Pharmaceuticals
Speech 13:20~13:50 Carlo Incerti
Senior Vice President, Head Global Medical Affairs,
Genzyme Corporation
Speech 13:50~14:20 Soon-Myung Paik
Newilhan Distinguished Professor,
Severance Biomedical Science Institute
Yonsei University College of Medicine
 Session 3. Creative Strategies for Global Top 10 in Pharmaceutical Industry   
Panel Discussion 14:30~16:00 <Moderator>
Dae-Kyong Kim
Chair, the Evaluation Committee for Life & Welfare,
National Science & Technology Commission in Korea

Seok-Jin Chung
Director, Bio&Nano Technology Division Ministry of Trade,
Industry & Energy
Young-Joo Hur
Director, Division of Emergency Healthcare and Preparedness,
Ministry of Health & Welfare
Yo-Up Lim
Director, Future Technology Division, Ministry of Science,
ICT and Future Planning(MSIP)
Jae-Du Ha
Director, Division of Drug Discovery Research,
Korea Research Institute of Chemical Technology

첨부파일

서울특별시 서초구 강남대로 315, 파이낸셜뉴스빌딩 9층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnmice.com
Copyright (c) fnMICE. All rights reserved.